RYOIX:NASDAQ
Rydex Biotechnology Fund Class Investor – RYOIX Fund Overview
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|
| 61.82 | -1.42 (-2.25%) | 61.82 - 82.61 | -- |
Market data as of 12:00AM 04/03/25. Quotes are delayed by at least 15 min.
Overview - RYOIX
The investment seeks to provide capital appreciation.
Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.
Growth of $10,000 (10 Years)
| Total Return | 9.78% |
|---|
| Yield (Trailing 12 Mo.) | 0.00% |
|---|
| Expense Ratio | 1.43% |
|---|
| Front Load | None |
|---|
| Deferred Load | None |
|---|
| Minimum Investment | $2,500 |
|---|
| Management Tenure | 27 Years |
|---|
| Fund Inception | 04/01/1998 |
|---|
Trailing Total Returns - RYOIX
as of 03/31/2025
| Timeframe | RYOIX | S&P 500 | Health |
|---|
| 1 Month | -6.18% | -5.63% | -5.16% |
|---|
| 3 Month | -1.35% | -4.27% | -1.46% |
|---|
| Year-to-Date | -1.35% | -4.27% | -1.46% |
|---|
| 1 Year | -2.85% | 8.25% | -6.28% |
|---|
| 3 Year | 0.07% | 9.06% | -1.28% |
|---|
| 5 Year | 5.62% | 18.59% | 6.84% |
|---|
| 10 Year | 2.45% | 12.50% | 5.31% |
|---|
| Since Inception | 9.78% | 10.98% | -- |
|---|
Sector Allocation - RYOIX
as of 03/31/2025
| Basic Materials | | 2.93% |
|---|
| Consumer Cyclical | | 0.00% |
|---|
| Financial Services | | 0.00% |
|---|
| Real Estate | | 0.00% |
|---|
| Consumer Defensive | | 0.00% |
|---|
| Healthcare | | 97.07% |
|---|
| Utilities | | 0.00% |
|---|
| Communication Services | | 0.00% |
|---|
| Energy | | 0.00% |
|---|
| Industrials | | 0.00% |
|---|
| Technology | | 0.00% |
|---|
Asset Allocation - RYOIX
as of 03/31/2025
| By Percent | Short | 0% | Long | Net |
|---|
| Stock | 0.00 | | | 92.59 | 92.59 |
|---|
| Bond | 0.00 | | | 0.00 | 0.00 |
|---|
| Other | 2.35 | | | 0.00 | -2.35 |
|---|
| Foreign Stock | 0.00 | | | 7.11 | 7.11 |
|---|
| Foreign Bond | 0.00 | | | 0.00 | 0.00 |
|---|
| Total | 2.35 | | | 99.70 | 97.35 |
|---|
| Cash | 0.00 | | | 2.65 | 2.65 |
|---|
| Total Net Assets | $87.25M |
|---|
| Total Stock Holdings | 76 |
|---|
| Total Bond Holdings | 0 |
|---|
Top Ten Holdings - RYOIX
as of 03/31/2025
Valuation & Growth - RYOIX
as of 03/31/2025
| Valuation | RYOIX | Category Range |
|---|
| Price/Earnings | 27.80 | |
|---|
| Price/Book | 4.05 | |
|---|
| Price/Sales | 5.65 | |
|---|
| Price/Cash Flow | 15.06 | |
|---|
| Dividend Yield | 0.86 | |
|---|
| LT Earnings | 19.32 | |
|---|
| Historical Earnings | | |
|---|
| Sales Growth | 2.32 | |
|---|
| Cash-Flow Growth | -10.49 | |
|---|
| Book-Value Growth | 6.83 | |
|---|
